Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Bladder Mesh Lawsuit News: Jury Orders Boston Scientific To Pay $18.5 Million Award After Finding Company Liable For Selling Defective Mesh, The Oliver Law Group Reports
  • USA - English


News provided by

The Oliver Law Group

Nov 24, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Contact the Oliver Law Group P.C. for your free Transvaginal Mesh Lawsuit review by calling toll free 800-939-7878 today or visit http://www.legalactionnow.com.
Contact the Oliver Law Group P.C. for your free Transvaginal Mesh Lawsuit review by calling toll free 800-939-7878 today or visit http://www.legalactionnow.com.

Contact the Oliver Law Group P.C. for your free Transvaginal Mesh Lawsuit review by calling toll free 800-939-7878 today or visit http://www.legalactionnow.com

Post this

New York NY (PRWEB) November 24, 2014 -- Bladder Mesh Lawsuit News: A federal jury in West Virginia today ordered Boston Scientific Corp. to pay $18.5 million to four women who said they suffered such injuries as mesh erosion, organ damage and pain due to the company’s Obtryx transvaginal mesh implant, The Oliver Law Group P.C. reports. According to Bloomberg, U.S. District Court, jurors in the Southern District of West Virginia found Boston Scientific liable for selling defective pelvic mesh devices. The jury also determined that the company failed to adequately warn the women and their doctors about the risks associated with its Obtryx mesh implant. The 10-day trial combined claims from the four bladder mesh lawsuits filed by the women. (12-cv-8633) The Oliver Law Group P.C. notes that this is the second time this month that a federal jury has found Boston Scientific responsible for selling defective mesh products. On November 13, a federal court jury in Miami awarded $26.7 million to four women who said they were injured after using Boston Scientific’s Pinnacle pelvic mesh device. (14-cv-24061, U.S. District Court, Southern District of Florida)
[bloomberg.com/news/2014-11-20/boston-scientific-vaginal-mesh-victims-win-18-5-million.html, November 20, 2014]

Reuters reported that the trial in West Virginia ended with the jury also ordering Boston Scientific to pay damages to each of the four women ranging from $3.25 million to $4.25 million. Additionally, the jury found the company acted with “gross negligence” and awarded each woman $1 million in punitive damages. According to Reuters, the women alleged that they suffered such injuries as nerve damage, infection and pain during sex because of the Obtryx vaginal mesh device. Boston Scientific issued a statement to Reuters saying that the company did not agree with the verdict and is weighing its appeals options. Boston Scientific recently had a jury verdict reduced, Reuters reported. In September, a Texas state court jury awarded $73 million to a woman who said she suffered permanent injuries from the Obtryx bladder mesh. The trial judge reduced the award to $34.6 million. (Salazar v. Lopez, No. DC-1214349, District Court for Dallas County, 95th Judicial District of Texas (Dallas)
[reuters.com/article/2014/11/20/boston-scient-mesh-verdict-idUSL2N0TA1WS20141120, November 20, 2014]
[reuters.com/article/2014/11/14/boston-scient-mesh-verdict-idUSL2N0T33EY20141114, November 13, 2014]

According to the U.S. Food and Drug Administration (FDA), transvaginal mesh devices are used to support the bowel, bladder, and uterus when they weaken, drop from their normal position and bulge into the vagina. The FDA issued warnings about pelvic mesh devices in 2008 and 2011 due to complaints received from women who suffered vaginal scarring, bleeding, shrinkage, pelvic pain and other complications after they had transvaginal mesh implants. In September 2011, the FDA convened a meeting of its Obstetrics and Gynecology Devices Panel to discuss concerns over transvaginal mesh products. The panel recommended that the FDA reclassify the transvaginal mesh devices from “moderate risk” to “high risk” because the safety and effectiveness of the devices have not been established.
[federalregister.gov/articles/2014/05/01/2014-09907/reclassification-of-surgical-mesh-for-transvaginal-pelvic-organ-prolapse-repair-and-surgical, May 1, 2014]

Court records indicate that pelvic mesh lawsuits filed against Boston Scientific continue to increase in the U.S. District Court, Southern District of West Virginia where pelvic mesh lawsuits are pending in multidistrict litigation. The court’s master case list shows mesh lawsuit complaints against Boston Scientific rose from 14,094 as of October 15, to 14,272 as of November 17. The pelvic mesh lawsuits were filed on behalf of women who allege that they suffered from mesh erosion, vaginal scarring, bleeding, pelvic pain and other problems as a result of having a transvaginal mesh implant. The mesh complaints contend that some of the plaintiffs had surgery to remove the mesh implants. (In Re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326)
[jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-November-17-2014.pdf, November 17, 2014]
Bloomberg reported that Boston Scientific’s loss of three trials since September adds pressure to the company to settle thousands of pending lawsuits. In its third quarter filing to the U.S. Securities and Exchange Commission, Boston Scientific reported that in addition to the multidistrict litigation in West Virginia, over 2,500 transvaginal mesh lawsuits are pending against the company (in Middlesex County Superior court) in Massachusetts.
[bloomberg.com/news/2014-11-20/boston-scientific-vaginal-mesh-victims-win-18-5-million.html, November 20, 2014]
[sec.gov/Archives/edgar/data/885725/000088572514000030/q32014form10q.htm, September 30, 2014]

About The Oliver Law Group P.C. And Filing A Transvaginal Mesh Lawsuit

Oliver Law Group P.C. is a different kind of law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights.

The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust.
Experience. Dedication. Trust. Oliver Law Group P.C.

If you would like to learn more about filing a Bladder Mesh Lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the Oliver Law Group P.C. for your free Transvaginal Mesh Lawsuit review by calling toll free 800-939-7878 today or visit http://www.legalactionnow.com.

Alyson Oliver, The Oliver Law Group, http://www.legalactionnow.com, +1 800-939-7878, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.